Your browser doesn't support javascript.
loading
First Co-Occurrence of Griscelli Syndrome Type 2 and Neurofibromatosis Type 1.
Kendir-Demirkol, Yasemin; Yeter, Burcu; Yararbas, Kanay.
Afiliación
  • Kendir-Demirkol Y; Department of Pediatric Genetics, Health Science University, Ümraniye Education and Research Hospital, Istanbul, Turkey.
  • Yeter B; Department of Pediatric Genetics, Health Science University, Ümraniye Education and Research Hospital, Istanbul, Turkey.
  • Yararbas K; Department of Medical Genetics, Demiroglu Bilim University, Istanbul, Turkey.
Mol Syndromol ; 15(3): 247-250, 2024 Jun.
Article en En | MEDLINE | ID: mdl-38841328
ABSTRACT

Introduction:

Griscelli syndrome type 2 (GS2) and neurofibromatosis type 1 (NF1) are both rare genetic disorders, but their coexistence has not been documented prior to this report. Case Presentation We present the case of a 4-year-old girl initially diagnosed with GS2 due to albinism and immunodeficiency, and later with NF1, manifested by the development of multiple café-au-lait macules (CALMs) and MRI findings. The patient was the second child of consanguineous parents and exhibited symptoms early, with silver-gray hair at birth and subsequent health complications at 9 months. GS2 was confirmed via the identification of a homozygous frameshift variant in the RAB27A gene, and a de novo heterozygous splice site mutation in the NF1 gene established the NF1 diagnosis. Her treatment included hematopoietic stem cell transplantation and ongoing surveillance for NF1-associated complications. Discussion/

Conclusion:

This case emphasizes the importance of considering the potential for concurrent rare genetic diseases in clinical evaluations, especially with progressive or evolving symptomatology.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Mol Syndromol Año: 2024 Tipo del documento: Article País de afiliación: Turquía

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Mol Syndromol Año: 2024 Tipo del documento: Article País de afiliación: Turquía